IPCA Laboratories Limited (IPCALAB) — Board Meeting | 13 August 2026 (2 announcements)

IPCA Laboratories held its 76th Annual General Meeting on August 13, 2026 via video conference, adopting audited financial statements for FY2026, declaring a dividend, and reappointing directors including Prashant Godha as Executive Director. Shareholders used e-voting between August 10-12, 2026, with results to be posted online post-scrutiny.

The Board approved unaudited Q1 FY27 results showing consolidated revenue of ₹2,308.85 crores (up 21% YoY) and profit before tax of ₹572.08 crores, driven by strong formulations and API growth. Exceptional items included a ₹30.42 crore impact from new Labour Codes, while the amalgamation of Krebs Biochemicals was approved with an effective date of April 1, 2026. The auditor issued an unmodified limited review report confirming compliance with IND-AS and SEBI regulations.